Three-year results of ST-segment elevation myocardial infarction patients treated with a prespecified bioresorbable vascular scaffold implantation strategy: bVS STEMI STRATEGY-IT long-term

J Cardiovasc Med (Hagerstown). 2022 Apr 1;23(4):278-280. doi: 10.2459/JCM.0000000000001286.
No abstract available

Publication types

  • Letter

MeSH terms

  • Absorbable Implants
  • Drug-Eluting Stents*
  • Humans
  • Percutaneous Coronary Intervention* / adverse effects
  • Percutaneous Coronary Intervention* / methods
  • Prosthesis Design
  • ST Elevation Myocardial Infarction* / diagnostic imaging
  • ST Elevation Myocardial Infarction* / surgery
  • Treatment Outcome